Actively Recruiting
Observing Cognitive and Eye Movement Changes in Rett Syndrome Patients Starting Trofinetide Treatment
Led by University of Minnesota · Updated on 2026-06-18
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying cognitive functions in individuals with Rett Syndrome, a severe intellectual and developmental disability IDD. The study focuses on assessing attention, learning, eye movement, and autonomic function using non-invasive measures during treatment with trofinetide, a recently FDA-approved medication for Rett Syndrome. This observational study aims to understand how these cognitive and physiological measures change over time and in response to treatment, addressing challenges in measuring cognition in this population due to motor and verbal impairments. Participants who are starting trofinetide treatment at the Gillette Childrens Rett Syndrome clinic will be observed. The study includes two assessments before treatment and one follow-up assessment four weeks after starting trofinetide. Additional optional follow-up visits may occur for families who continue standard care or are willing to travel for research visits. No experimental treatments are administered as this is an observational study. During the study, participants will complete eye-tracking tasks and other psychophysiological tests to measure attention, eye movement gaze fixations, heart rate variability, and heart rate suppression. These measures will be collected at baseline and from 6 weeks up to 12 months after treatment begins. Researchers will monitor changes over time and any developmental or health changes. Participation involves non-invasive assessments and follow-up visits, with the total duration extending up to 12 months.
CONDITIONS
Brief Title
Cognitive Function in Rett Syndrome During Trofinetide Treatment
Research Team
B
Breanne Byiers
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here